Simple jQuery Dropdowns

Browsing by Author Carter Lee

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-May-2017Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B. Gilbert; Jean Louis Excler; Georgia D. Tomaras; Lindsay N. Carpp; Barton F. Haynes; Hua Xin Liao; David C. Montefiori; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Gustavo H. Kijak; Sodsai Tovanabutra; Donald P. Francis; Carter Lee; Faruk Sinangil; Phillip W. Berman; Nakorn Premsri; Prayura Kunasol; Robert J. O'Connell; Nelson L. Michael; Merlin L. Robb; Rhoda Morrow; Lawrence Corey; Jerome H. Kim; Fred Hutchinson Cancer Research Center; University of Washington, Seattle; HJF; Walter Reed Army Institute of Research; Duke University School of Medicine; Duke University Medical Center; Thailand Ministry of Public Health; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions for Infectious Diseases; University of California, Santa Cruz; International Vaccine Initiative
1-Aug-2012Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trialsDavid C. Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S. De Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M. Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C. Labranche; Charla Andrews; Victoria R. Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G. Self; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L. Robb; Barton F. Haynes; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Armed Forces Research Institute of Medical Sciences, San Francisco; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; University of Alabama; Ministry of Public Health; Mahidol University; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Sanofi Pasteur
26-Sep-2013Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy TrialRaphael Gottardo; Robert T. Bailer; Bette T. Korber; S. Gnanakaran; Joshua Phillips; Xiaoying Shen; Georgia D. Tomaras; Ellen Turk; Gregory Imholte; Larry Eckler; Holger Wenschuh; Johannes Zerweck; Kelli Greene; Hongmei Gao; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Merlin L. Robb; Nelson L. Michael; Jerome H. Kim; Susan Zolla-Pazner; Barton F. Haynes; John R. Mascola; Steve Self; Peter Gilbert; David C. Montefiori; Fred Hutchinson Cancer Research Center; National Institute of Allergy and Infectious Diseases; Los Alamos National Laboratory; Duke University School of Medicine; JPT Peptide Technologies GmbH; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Thailand Ministry of Public Health; Mahidol University; Department of Research and Development; Walter Reed Army Institute of Research; VA Medical Center; NYU School of Medicine
15-May-2012The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S. De Souza; Silvia Ratto-Kim; Weerawan Chuenarom; Alexandra Schuetz; Somsak Chantakulkij; Bessara Nuntapinit; Anais Valencia-Micolta; Doris Thelian; Sorachai Nitayaphan; Punnee Pitisuttithum; Robert M. Paris; Jaranit Kaewkungwal; Nelson L. Michael; Supachai Rerks-Ngarm; Bonnie Mathieson; Mary Marovich; Jeffrey R. Currier; Jerome H. Kim; Supamit Chunsuttiwat; Nakorn Premsri; Chawetsan Namwat; Prayura Kunasol; Prasert Thongcharoen; Chirasak Khamboonruang; Valai Bussaratid; Wirach Maek-a-nantawat; Jittima Dhitavat; Pravan Suntharasamai; Swangjai Pungpak; Siriwan Vanijanonta; Jaranit Kaewkunwal; Amnat Khamsiriwatchara; Pawinee Jarujareet; Chirapa Easmila; Suchana Tabprasit; Viseth Ngauy; Robert Paris; Michael Benenson; Patricia Morgan; Arthur Brown; Mark De Souza; Rapee Trichavaroj; Nusara Thaitawat; Kanyasiri Kongnonkok; Boot Keawboon; Yuwadee Phuang-Ngern; Susan Mason; Sanjay Gurunathan; Jim Tartaglia; John G. McNeil; Robin Harkness; Claude Meric; Lynn Baglyos; Raphaelle El Habib; Don Francis; Carter Lee; Elizabeth Adams; Merlin L. Robb; Mark Milazzo; Amy Bolen; Beryl Wessner; Jeffrey Currier; Deborah L. Birx; Don Stablein; Terry Germanson; Len Dally; Jean Louis Excler; Jeffrey Berenberg; Armed Forces Research Institute of Medical Sciences, Thailand; Walter Reed Army Institute of Research; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; Sanofi Pasteur; Sanofi Pasteur; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; U.S. Army Medical Research and Materiel Command; Centers for Disease Control and Prevention; The EMMES Corporation; International AIDS Vaccine Initiative; Tripler Regional Med Center
19-Mar-2014Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccinationNicole L. Yates; Hua Xin Liao; Youyi Fong; Allan DeCamp; Nathan A. Vandergrift; William T. Williams; S. Munir Alam; Guido Ferrari; Zhi Yong Yang; Kelly E. Seaton; Phillip W. Berman; Michael D. Alpert; David T. Evans; Robert J. O'Connell; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Abraham Pinter; Susan Zolla-Pazner; Peter B. Gilbert; Gary J. Nabel; Nelson L. Michael; Jerome H. Kim; David C. Montefiori; Barton F. Haynes; Georgia D. Tomaras; Duke University; Fred Hutchinson Cancer Research Center; National Institute of Allergy and Infectious Diseases; University of California, Santa Cruz; Harvard Medical School; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions for Infectious Diseases; Thailand Ministry of Public Health; Mahidol University; Sanofi Pasteur; Rutgers New Jersey Medical School; NYU School of Medicine; Walter Reed Army Institute of Research; Sanofi; University of Wisconsin Madison